Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Dyne Therapeutics Inc (NASDAQ: DYN) closed at $19.56 in the last session, up 1.87% from day before closing price of $19.2. In other words, the price has increased by $1.87 from its previous closing price. On the day, 1.36 million shares were traded. DYN stock price reached its highest trading level at $19.81 during the session, while it also had its lowest trading level at $19.05.
Ratios:
We take a closer look at DYN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 13.47 and its Current Ratio is at 13.47. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
Raymond James Upgraded its Outperform to Strong Buy on August 25, 2025, while the target price for the stock was maintained at $35.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 05 ’25 when Kerr Douglas bought 880 shares for $20.72 per share.
Cox John bought 2,662 shares of DYN for $55,150 on Dec 05 ’25. On Dec 05 ’25, another insider, Cox John, who serves as the CEO & President of the company, sold 2,662 shares for $20.72 each. As a result, the insider received 55,157 and left with 196,877 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 3220597760 and an Enterprise Value of 2122229888.
Stock Price History:
The Beta on a monthly basis for DYN is 1.31, which has changed by -0.21001613 over the last 52 weeks, in comparison to a change of 0.15196204 over the same period for the S&P500. Over the past 52 weeks, DYN has reached a high of $26.22, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is -2.98%, while the 200-Day Moving Average is calculated to be 42.64%.
Shares Statistics:
According to the various share statistics, DYN traded on average about 2.87M shares per day over the past 3-months and 1816640 shares per day over the past 10 days. A total of 142.61M shares are outstanding, with a floating share count of 118.92M. Insiders hold about 26.51% of the company’s shares, while institutions hold 73.77% stake in the company. Shares short for DYN as of 1765756800 were 14949400 with a Short Ratio of 5.21, compared to 1763078400 on 17111938. Therefore, it implies a Short% of Shares Outstanding of 14949400 and a Short% of Float of 9.98.
Earnings Estimates
A comprehensive evaluation of Dyne Therapeutics Inc (DYN) is underway, with the input of 10.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.82, with high estimates of -$0.65 and low estimates of -$1.0.
Analysts are recommending an EPS of between -$3.39 and -$3.83 for the fiscal current year, implying an average EPS of -$3.55. EPS for the following year is -$3.32, with 12.0 analysts recommending between -$2.73 and -$4.32.
